AI assistant
CAMBRIDGE NUTRITIONAL SCIENCES PLC — Director's Dealing 2014
Nov 28, 2014
7544_dirs_2014-11-28_5a3cc27d-ba23-4a12-b9e0-22b1b8021c95.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3090Y
Omega Diagnostics Group PLC
28 November 2014
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director's Dealing
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Andrew Shepherd, Chief Executive Officer of the Company, today purchased 30,974 ordinary shares in the Company at 17p per share through his SIPP.
Following this transaction, Mr Shepherd's total beneficial holding has increased to 2,677,206 ordinary shares representing 2.5 per cent of the issued ordinary share capital of the Company.
Contacts:
| Omega Diagnostics Group PLC | Tel: 01259 763 030 or www.omegadiagnostics.com |
| Andrew Shepherd, Chief Executive | |
| Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director |
|
| finnCap Ltd | Tel: 020 7220 0500 |
| Geoff Nash/Christopher Raggett (Corporate Finance) Mia Gardner (Corporate Broking) |
|
| Walbrook PR Limited | Tel: 020 7933 8780 or [email protected] |
| Paul McManus | Mob: 07980 541 893 |
| Lianne Cawthorne | Mob: 07584 391 303 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSPGGPWGUPCGUR